Susquehanna International Group, LLP Insmed Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $11.7 Million - $14.9 Million	-188,400 Reduced 29.89%	441,900 $32.3 Million
Q2 2024 Aug 15, 2024	BUY	$22.0 - $69.71 $12.5 Million - $39.5 Million	567,200 Added 898.89%	630,300 $42.2 Million
Q1 2024 May 07, 2024	BUY	$25.72 - $29.94 $1.2 Million - $1.39 Million	46,500 Added 280.12%	63,100 $1.71 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $323,196 - $438,012	-13,800 Reduced 45.39%	16,600 $514,000
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $317,760 - $430,880	16,000 Added 111.11%	30,400 $767,000
Q2 2023 Aug 11, 2023	BUY	$16.44 - $21.1 $46,032 - $59,080	2,800 Added 24.14%	14,400 $303,000
Q1 2023 May 16, 2023	BUY	$16.26 - $21.73 $188,616 - $252,068	11,600 New	11,600 $197,000
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $286,056 - $386,477	13,700 Added 45.67%	43,700 $941,000
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $134,853 - $203,109	-7,900 Reduced 20.84%	30,000 $592,000
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $584,012 - $804,518	28,600 Added 307.53%	37,900 $891,000
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $823,302 - $1.06 Million	-31,800 Reduced 77.37%	9,300 $253,000
Q1 2021 May 17, 2021	BUY	$32.28 - $44.3 $865,104 - $1.19 Million	26,800 Added 187.41%	41,100 $1.4 Million
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $1.32 Million - $1.71 Million	-42,100 Reduced 74.65%	14,300 $476,000
Q3 2020 Nov 16, 2020	SELL	$26.0 - $34.5 $252,200 - $334,650	-9,700 Reduced 14.67%	56,400 $1.81 Million
Q2 2020 Aug 14, 2020	SELL	$14.11 - $29.42 $577,099 - $1.2 Million	-40,900 Reduced 38.22%	66,100 $1.82 Million
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $1.65 Million - $4.11 Million	-121,000 Reduced 53.07%	107,000 $1.72 Million
Q4 2019 Feb 14, 2020	BUY	$16.12 - $24.98 $1.49 Million - $2.32 Million	92,700 Added 68.51%	228,000 $5.45 Million
Q3 2019 Nov 14, 2019	SELL	$15.49 - $25.78 $255,585 - $425,370	-16,500 Reduced 10.87%	135,300 $2.39 Million
Q2 2019 Aug 14, 2019	SELL	$23.0 - $32.19 $3.34 Million - $4.67 Million	-145,100 Reduced 48.87%	151,800 $3.89 Million
Q1 2019 May 15, 2019	BUY	$13.91 - $31.15 $788,697 - $1.77 Million	56,700 Added 23.61%	296,900 $8.63 Million
Q4 2018 Feb 14, 2019	SELL	$11.6 - $18.7 $1.64 Million - $2.64 Million	-141,400 Reduced 37.05%	240,200 $3.15 Million
Q3 2018 Nov 14, 2018	BUY	$18.95 - $28.08 $4.48 Million - $6.64 Million	236,400 Added 162.81%	381,600 $7.72 Million
Q2 2018 Aug 14, 2018	SELL	$20.0 - $29.72 $1.13 Million - $1.68 Million	-56,500 Reduced 28.01%	145,200 $3.43 Million
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $1.79 Million - $2.72 Million	82,500 Added 69.21%	201,700 $4.54 Million
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $11.3 Million - $13.6 Million	-427,500 Reduced 78.2%	119,200 $3.72 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $6.35 Million - $17.1 Million	546,700	546,700 $17.1 Million

Others Institutions Holding INSM

# of Institutions

465

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

Vanguard Group Inc Valley Forge, PA

17.1M
Shares

$1.14 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

14.3M
Shares

$946 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

12.6M
Shares

$834 Million
0.11% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

10.5M
Shares

$696 Million
62.32% of portfolio
Capital International Investors Los Angeles, CA

6.52M
Shares

$432 Million
0.09% of portfolio

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account